A recap of the top women's health headlines from October 2026, including FDA approval of pritelivir for refractory HSV, ACOG's new menopause guideline, and more.
|Slideshows|August 6, 2020
- Vol 65 No 08
- Volume 64
- Issue 08
Terminology for ob/gyns to use when treating transgender patients
Transgender and nonbinary people face disproportionate rates of stigma and discrimination in seeking healthcare—and may encounter additional unique barriers in attaining gynecologic and reproductive care.
Advertisement
In this month's issue of Contemporary OB/GYN, Drs. Crissman and Stroumsa authored a feature story that discussed the needs of transgender and nonbinary people.
Excerpt:
"Ob/gyns have the opportunity to play a significant role in improving access to quality gynecologic and reproductive care for transgender and nonbinary people. This can be done with relative ease, with compassion, gender-inclusive practices, sensitivity to patients’ lived experiences, and a modest expansion of the traditional baseline knowledge regarding hormones and gender-affirming medical interventions."
The following are terms and definitions Drs. Crissman and Stroumsa provided to help ob/gyns use correct and appropriate terminology when caring for patients.
Articles in this issue
about 6 years ago
Was loss of ovary in this pediatric case avoidable?about 6 years ago
August issue roundup: Vol 65 No 08about 6 years ago
Resources for transgender careabout 6 years ago
Overcoming racism and unconscious bias in ob/gynabout 6 years ago
Gynecologic care considerations for transmasculine peopleabout 6 years ago
AUGS: Vaginal Energy-Based Devicesabout 6 years ago
Addressing inequalities in women's health researchabout 6 years ago
Chairman's message: Implicit bias and racismover 6 years ago
Ensuring racial justice and health equity in ob/gynAdvertisement
Related to this article
Peter Hsin, BS, discusses a meta-analysis linking perioperative ketamine to lower early postpartum depressive symptoms after cesarean delivery.
The FDA granted accelerated approval to Voceryq to reduce papilloma excision surgeries in adults with recurrent respiratory papillomatosis.
Neither maternal MOUD dose nor umbilical cord opioid levels were associated with neonatal opioid withdrawal syndrome severity.
ACOG advises against GLP-1 receptor agonists in pregnancy and recommends considering discontinuation 1 to 2 months before conception.
Cultural upbringing gives context to sexual dysfunction but does not make the diagnosis, according to Sameena Rahman, MD, FACOG.
Experts address COVID-19 vaccine myths, safety evidence, and how to frame the benefits of vaccination in pregnancy.
Lisa Taylor-Swanson, PhD, on a pilot in which integrative group medical visits improved menopause symptoms, knowledge, and self-efficacy.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Choosing Among Hormonal and Nonhormonal VMS Therapies in Menopause
2
FDA removes boxed warnings from 3 more menopausal hormone therapy products
3
Top video interviews from The Menopause Society 2026 Annual Meeting
4
Top headlines in women's health from October 2026
5